These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2735737)

  • 1. [Classification of primary dyslipoproteinemias].
    Ziegler O; Jan P; Got I; Drouin P
    Ann Cardiol Angeiol (Paris); 1989 May; 38(5):243-8. PubMed ID: 2735737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic aspects of primary atherogenic dyslipoproteinemia].
    Turpin G; Bruckert E
    C R Seances Soc Biol Fil; 1995; 189(5):905-17. PubMed ID: 8673636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Classification of hyperlipoproteinemias and interpretation of laboratory parameters].
    Herrmann W; Lackner KJ; Schmitz G
    Wien Med Wochenschr; 1994; 144(12-13):292-9. PubMed ID: 8650932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Classification of dyslipoproteinemias of genetic origin].
    Brousseau T; Fruchart JC
    Ann Med Interne (Paris); 1993; 144(4):275-81. PubMed ID: 8368721
    [No Abstract]   [Full Text] [Related]  

  • 5. Risks for hyperlipidemia.
    Nestruck AC; Davignon J
    Cardiol Clin; 1986 Feb; 4(1):47-56. PubMed ID: 2871933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Classification of disorders of lipid metabolism].
    Richter WO; Schwandt P
    Internist (Berl); 1992 Nov; 33(11):728-31. PubMed ID: 1478827
    [No Abstract]   [Full Text] [Related]  

  • 7. The hyperlipoproteinemias. A simplified classification and approach to therapy.
    Zelis R; Mason DT; Spann JF
    Calif Med; 1970 May; 112(5):32-7. PubMed ID: 4924875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of atherogenic hyperlipidemia].
    Turpin G; Bruckert E
    Ann Cardiol Angeiol (Paris); 1998 Nov; 47(9):627-32. PubMed ID: 9864558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [From Fredrickson's classification of phenotypes--lipoprotein patterns--to genotype comprehension].
    Campos EM
    Acta Med Port; 2005; 18(3):189-98. PubMed ID: 16207455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of primary dyslipoproteinemias.
    Dargel R
    Exp Pathol; 1985; 27(2):67-78. PubMed ID: 3888651
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of dyslipoproteinemia with the use of plasma total cholesterol and triglyceride as screening tests. The Lipid Research Clinics Program Prevalence Study.
    Kwiterovich PO; Stewart P; Probstfield JL; Stinnett S; Chambless LE; Chase GA; Jacobs DR; Morrison JA
    Circulation; 1986 Jan; 73(1 Pt 2):I30-9. PubMed ID: 3940681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnosis and treatment of the hyperlipoproteinemias: emphasis on Types IIa, IIb and IV.
    Frommeyer WB
    Ala J Med Sci; 1974 Jul; 11(3):207-14. PubMed ID: 4375414
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of 1 month's treatment with Bezalip on the serum lipids and lipoproteins of patients with different types of hyperlipoproteinemias].
    Kiriakov A; Malamov E; Apostolova Iu; Tsenov I; Tinterova Z
    Vutr Boles; 1983; 22(3):74-81. PubMed ID: 6649587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Classification of hyperlipoproteinemia. II. Distribution principle of hyperlipoproteinemias according to Fredrickson et al. correlated with clinical dermatological possibilities].
    Zabel R
    Dermatol Monatsschr; 1973 Dec; 159(12):1137-43. PubMed ID: 4366868
    [No Abstract]   [Full Text] [Related]  

  • 15. [Genetic aspects of atherogenic dyslipoproteinemias].
    de Gennes JL
    Ann Biol Clin (Paris); 1986; 44(5):556-8. PubMed ID: 3813140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis, clinical features and treatment of hyperlipidemias in children].
    Widhalm K
    Monatsschr Kinderheilkd; 1982 Oct; 130(10):747-52. PubMed ID: 7177116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperlipidemia.
    Sloan RW
    Am Fam Physician; 1983 Sep; 28(3):171-82. PubMed ID: 6613796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
    Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P
    Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary hyperlipoproteinemias].
    Cassani C
    G Clin Med; 1972 Nov; 53(11):553-61. PubMed ID: 4667385
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of fenofibrate in various types of hyperlipoproteinemias].
    Sucić M
    Lijec Vjesn; 1989 Mar; 111(3):93-7. PubMed ID: 2747411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.